FDAは、進行子宮体がんにレンバチニブ、ペンブロリズマブ併用療法を仮承認しました。現在、第三相試験が進行中です。 FDA Grants Approval to Lenvatinib/Pembrolizumab in Advanced Endometrial Cancer https://www.ascopost.com/news/september-2019/fda-grants-approval-to-lenvatinibpembrolizumab-in-advanced-endometrial-cancer-announces-project-orbis/?utm_source=TAP%20Evening%20News%20Emails&utm_medium=Email&utm_campaign=TAP%20Evening%20News%20Emails%209.12.2019&email=89f7935b2d77efac183ad0af3bfe8807f3450a85d06d2bf9889cc8d0f666f369…
posted at 07:49:56